RNR
RenaissanceRe Holdings Ltd.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
323.45
▲ 1.30 (0.40%)
MARKET · —
Price
Open
322.15
Prev close
322.15
Day high
325.21
Day low
321.17
Volume
310.14K
Market cap
$13.44B
P/E (TTM)
5.61
52W range
231.17 – 335.97
Trailing performance
Returnvs SPY
1W
+0.03%
+1.4%
1M
+1.90%
-1.8%
3M
+7.62%
+4.5%
6M
+8.18%
-2.9%
YTD
+15.04%
+2.8%
1Y
+30.40%
+10.4%
3Y
+76.19%
+2.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$13.44B
Enterprise value$-6.57B
Revenue (TTM)$11.17B
Gross profit$5.06B
EBITDA—
Net income$2.56B
EPS (TTM)$57.67
Free cash flow$2.79B
Total cash$30.44B
Total debt$2.34B
Book value / share$264.77
Shares outstanding41.55M
Float40.47M
Short % of float4.11%
Dividend yield0.51%
Beta (5Y)0.17
Valuation & profitability ratios
Trailing P/E5.61
Forward P/E7.89
PEG ratio3.62
Price / sales—
Price / book1.22
EV / revenue-0.59
EV / EBITDA—
Gross margin45.35%
Operating margin41.67%
Profit margin23.58%
Return on equity21.48%
Return on assets5.19%
Debt / equity12.21
Current ratio1.35
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $9.87B | $9.95B | $7.47B | $7.20B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $2.65B | $1.83B | $2.53B | -$1.10B |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $2.65B | $1.83B | $2.53B | -$1.10B |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 11.75 | 12.92 | +10.0% |
| Mar 2026 | 11.22 | 13.75 | +22.5% |
| Dec 2025 | 10.41 | 13.34 | +28.2% |
| Sep 2025 | 9.50 | 15.62 | +64.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 6.77 | 15 | $1.78B | -13.6% |
| Next quarter | 8.72 | 4 | $1.41B | -11.7% |
| Current year | 43.39 | 17 | $8.14B | -17.6% |
| Next year | 39.68 | 4 | $8.06B | -0.9% |
Analyst targets & ownership
Mean target$346.40
High target$438.00
Low target$304.00
Implied upside7.10%
Analyst count15
ConsensusHOLD
Strong buy / Buy0 / 4
Hold12
Sell / Strong sell1 / 0
Held by insiders2.29%
Held by institutions99.86%
Institutions holding766
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+78.10K
Net buying
Buy transactions
19
89.58K shares
Sell transactions
3
11.48K shares
Net transactions
+22
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
952.37K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | CURTIS ROSS A Officer |
SELL | 5.00K | $1.63M | Direct |
| Jul 28, 26 | QUTUB ROBERT Chief Financial Officer |
SELL | 5.00K | $1.67M | Direct |
| May 18, 26 | SANDERS CAROL P Director |
SELL | 1.48K | $439.79K | Direct |
| May 11, 26 | KLEHM HENRY Director |
STOCK | 506 | $0 | Direct |
| May 11, 26 | HOOLEY STEPHEN C Director |
STOCK | 591 | $0 | Direct |
| Feb 27, 26 | GIBBONS JAMES L Director |
STOCK | 1.07K | $0 | Direct |
| Feb 27, 26 | TRUDELL CYNTHIA MARY Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | BUSHNELL DAVID C Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | O'DONNELL KEVIN J. Chief Executive Officer |
STOCK | 34.38K | $0 | Direct |
| Feb 27, 26 | HENNES DUNCAN P Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | GIDUMAL SHYAM H Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | SANDERS CAROL P Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | KLEHM HENRY Director |
STOCK | 578 | $0 | Direct |
| Feb 27, 26 | CURTIS ROSS A Officer |
STOCK | 10.25K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BENDER SHANNON LOWRY |
General Counsel | 38.13K | Stock Award(Grant) |
BROSNAN SEAN G. |
Chief Investment Officer | 40.56K | Stock Award(Grant) |
BUSHNELL DAVID C |
Director | 13.44K | Stock Award(Grant) |
CURTIS ROSS A |
Officer | 170.99K | Sale |
FRASER JAMES CHRISTOPHER |
Officer | 15.10K | Stock Award(Grant) |
GIBBONS JAMES L |
Director | 32.46K | Stock Award(Grant) |
KLEHM HENRY |
Director | 20.82K | Stock Award(Grant) |
MARRA DAVID E. |
Officer | 98.75K | Stock Award(Grant) |
O'DONNELL KEVIN J. |
Chief Executive Officer | 447.97K | Stock Award(Grant) |
QUTUB ROBERT |
Chief Financial Officer | 72.91K | Sale |
Moving averages & technicals
SMA 10
319.77
+1.15% from price
SMA 20
322.19
+0.39% from price
SMA 50
317.24
+1.96% from price
SMA 100
308.11
+4.98% from price
SMA 200
294.80
+9.72% from price
EMA 12
320.87
+0.80% from price
EMA 26
319.98
+1.08% from price
EMA 50
316.19
+2.30% from price
RSI (14)
54.2
Neutral
MACD (12,26,9)
0.89
Hist -0.38
ATR (14)
6.10
1.89% of price
Realised vol 30D
25.4%
Annualised
Bollinger upper
331.57
20, 2σ
Bollinger lower
312.81
20, 2σ
50 / 200 cross
Golden
317.24 vs 294.80
Trend bias
Above 200
+9.72%
Risk profile
Beta vs SPY
-0.44
Less volatile than market
Correlation to SPY
-0.23
Largely independent
Realised vol 30D
25.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-13.3%
Peak to trough
Max drawdown 5Y
-28.1%
Peak to trough
ATR 14
6.10
1.89% of price
Beta (reported)
0.17
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
20.20
Positioning, not flow
Max pain
330.00
+2.0% from spot
ATM implied vol
24.6%
Nearest strike to spot
Skew (10% OTM)
+12.1%
Puts bid over calls
Call volume
0
Contracts, this expiry
Put volume
7
Contracts, this expiry
Heaviest call OI
330.00
5 contracts
Heaviest put OI
290.00
84 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Why Is RenaissanceRe (RNR) Up 1.5% Since Last Earnings Report?
Zacks · 1d ago
3 Insurance Stocks That Concern Us
StockStory · 1d ago
NMIH Gains 20.9% in Three Months: What Investors Should Know?
Zacks · 2d ago
FAF Stock Trading at a Discount to Industry at 1.30X: Time to Hold?
Zacks · 10d ago
Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?
Zacks · 11d ago
RenaissanceRe (RNR) Stock Looks Undervalued On Earnings But Risky On Loss Exposure
Simply Wall St. · 14d ago
MetLife Tops Q2 Earnings Estimates on Strong Investment Income
Zacks · 16d ago
Allstate Q2 Earnings Beat Estimates on Higher Investment Income
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.